Crossmark

Avances recientes en la prevención de la enfermedad meningocócica B: evidencia real de la vacunación con 4CMenB

Crossref DOI link: https://doi.org/10.1016/j.vacun.2021.07.002

Published Print: 2021-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Martinón-Torres, F. http://orcid.org/0000-0002-9023-581X
Banzhoff, A. http://orcid.org/0000-0002-8813-282X
Azzari, C. http://orcid.org/0000-0001-7236-1655
de Wals, P. http://orcid.org/0000-0002-9239-3096
Marlow, R. http://orcid.org/0000-0002-3192-3102
Marshall, H. http://orcid.org/0000-0003-2521-5166
Pizza, M. http://orcid.org/0000-0002-7800-1404
Rappuoli, R. http://orcid.org/0000-0002-8827-254X
Bekkat-Berkani, R. http://orcid.org/0000-0003-0683-6055
License Information

Text and Data Mining valid from 2021-09-01

Text and Data Mining valid from 2021-09-01

Version of Record valid from 2021-09-02
More Information

This article is maintained by: Elsevier

Article Title: Avances recientes en la prevención de la enfermedad meningocócica B: evidencia real de la vacunación con 4CMenB

Journal Title: Vacunas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vacun.2021.07.002

Content Type: article

Copyright: © 2021 GlaxoSmithKline Biologicals S.A. Published by Elsevier España, S.L.U.